Publications in collaboration with researchers from Università de Roma La Sapienza (9)

2023

  1. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry

    European Journal of Internal Medicine, Vol. 107, pp. 60-65

2022

  1. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

    Age and ageing, Vol. 51, Núm. 8

2020

  1. 'Real-world' observational studies in arrhythmia research: Data sources, methodology, and interpretation. A position document from european heart rhythm association (EHRA), endorsed by heart rhythm society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)

    Europace, Vol. 22, Núm. 5, pp. 831-832

2019

  1. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)

    Europace, Vol. 21, Núm. 1, pp. 7-8

2018

  1. Comparison of the 2MACE and TIMI-AF scores for composite clinical outcomes in anticoagulated atrial fibrillation patients

    Circulation Journal, Vol. 82, Núm. 5, pp. 1286-1292

  2. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

    International Journal of Cardiology, Vol. 254, pp. 125-131

  3. Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)

    Annals of Medicine, Vol. 50, Núm. 6, pp. 511-518

  4. Predicting bleeding events in anticoagulated patients with atrial fibrillation: A comparison between the HAS-BLED and GARFIELD-AF bleeding scores

    Journal of the American Heart Association, Vol. 7, Núm. 18

2017

  1. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

    Europace, Vol. 19, Núm. 11, pp. 1757-1758